Jarlath Ffrench-Mullen

Neuroscience Genetics Consultant at Bristol-Myers Squibb

Jarlath ffrench-Mullen is a seasoned professional with extensive experience in translational research and biomarker development, currently serving as a Senior Consultant at Karuna Therapeutics, where responsibilities include leading initiatives in pharmacogenomics and precision medicine for Phase 3 trials. Jarlath has held advisory roles at AdvisoryCloud and worked as a Healthcare Consultant at Biotech Clinical Research, focusing on Phase 1 clinical trials and biomarker program design. Previously, Jarlath was a Senior Director at Takeda Pharmaceuticals, overseeing global neuroscience pharmacogenetic initiatives. Other notable positions include Director of Laboratory Services at DemeRx Inc., Director of Research at Brain Endowment Bank, and various leadership roles at GeneLogic and AstraZeneca. Jarlath's academic credentials include a Bachelor of Science in Zoology and a Ph.D. in Physiology from The George Washington University.

Links

Previous companies

Takeda Pharmaceutical logo
Karuna Therapeutics logo